US Stock MarketDetailed Quotes
NBTX Nanobiotix
- 6.050
- +0.050+0.83%
Close May 2 16:00 ET
- 6.200
- +0.150+2.48%
Pre 04:01 ET
285.16MMarket Cap-5224P/E (TTM)
6.070High6.010Low3.15KVolume6.010Open6.000Pre Close19.00KTurnover0.01%Turnover RatioLossP/E (Static)47.13MShares11.00052wk High-144.05P/B168.21MFloat Cap4.55052wk Low--Dividend TTM27.80MShs Float21.550Historical High--Div YieldTTM1.00%Amplitude1.750Historical Low6.038Avg Price1Lot Size
Nanobiotix Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 30.06M | 0 | -80.00%10K | -26.47%50K | -41.38%68K | -53.97%116K | -83.83%252K | 486.76%1.56M | -72.55%265.54K | 423.15%967.5K |
| Operating revenue | --30.06M | --0 | -80.00%10K | -26.47%50K | -41.38%68K | -53.97%116K | -83.83%252K | 486.76%1.56M | -72.55%265.54K | 423.15%967.5K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 21.70%56.84M | -11.19%46.7M | 44.16%52.59M | -22.13%36.48M | 55.20%46.85M | 18.28%30.18M | 9.00%25.52M | 34.50%23.41M | 64.42%17.41M | 26.58%10.59M |
| Selling and administrative expenses | 23.92%21.66M | -8.08%17.48M | 33.26%19.02M | -23.44%14.27M | 47.71%18.64M | 11.90%12.62M | 9.94%11.28M | --10.26M | ---- | ---- |
| -General and administrative expense | 23.92%21.66M | -8.08%17.48M | 33.26%19.02M | -23.44%14.27M | 47.71%18.64M | 11.90%12.62M | 9.94%11.28M | --10.26M | ---- | ---- |
| Research and development costs | 17.65%38.4M | 7.43%32.64M | 24.86%30.38M | -20.00%24.33M | 45.56%30.41M | 17.82%20.89M | 4.83%17.73M | 21.68%16.92M | 72.14%13.9M | 34.02%8.08M |
| Depreciation amortization depletion | -19.40%270K | -19.47%335K | 22.35%416K | 24.54%340K | 221.18%273K | 486.36%85K | -121.24%-22K | --103.57K | ---- | ---- |
| -Depreciation and amortization | -19.40%270K | -19.47%335K | 22.35%416K | 24.54%340K | 221.18%273K | 486.36%85K | -121.24%-22K | 53.91%103.57K | 264.62%67.29K | -86.62%18.46K |
| Other taxes | 3.72%-3.94M | -64.30%-4.09M | -29.22%-2.49M | 20.93%-1.93M | 25.04%-2.44M | 0.25%-3.25M | 12.00%-3.26M | ---3.7M | ---- | ---- |
| Other operating expenses | 30.61%448K | -93.49%343K | 1,082.65%5.27M | -1,240.00%-536K | 75.31%-40K | 22.86%-162K | -31.06%-210K | 95.48%-160.23K | -139.09%-3.55M | -11.97%-1.48M |
| Operating profit | 42.66%-26.78M | 11.17%-46.7M | -44.33%-52.58M | 22.13%-36.43M | -55.58%-46.78M | -19.00%-30.07M | -15.61%-25.27M | -27.49%-21.85M | -78.19%-17.14M | -17.61%-9.62M |
| Net non-operating interest income expense | 47.89%-6.48M | -1,789.97%-12.44M | -114.82%-658K | 197.48%4.44M | -527.41%-4.56M | -1,110.00%-726K | -146.05%-60K | -18.82%130.29K | 6.66%160.5K | 316.18%150.48K |
| Non-operating interest income | 375.39%1.22M | --256K | --0 | 4,353.33%4.68M | 208.82%105K | 3.03%34K | -44.53%33K | -67.53%59.49K | -6.83%183.22K | 232.97%196.65K |
| Non-operating interest expense | 36.75%7.98M | 769.90%5.84M | 101.50%671K | -93.05%333K | 465.88%4.79M | 684.26%847K | 5.67%108K | 71.72%102.2K | 6.80%59.52K | 126.81%55.73K |
| Total other finance cost | -104.16%-285K | 52,830.77%6.86M | 86.60%-13K | 27.07%-97K | -52.87%-133K | -480.00%-87K | 91.33%-15K | -370.11%-173K | -284.98%-36.8K | -472.40%-9.56K |
| Other net income (expense) | -400.19%-6.32M | -66.24%2.11M | 491.59%6.24M | -476.60%-1.59M | -5.79%423K | 155.09%449K | -1,140.83%-815K | -65.68K | ||
| Gain on sale of security | -400.19%-6.32M | -66.24%2.11M | 491.59%6.24M | -476.60%-1.59M | -5.79%423K | 155.09%449K | -1,140.83%-815K | ---65.68K | ---- | ---- |
| Special income (charges) | --0 | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 30.60%-39.58M | -21.35%-57.03M | -39.95%-47M | 34.04%-33.58M | -67.77%-50.91M | -16.07%-30.35M | -19.98%-26.14M | -28.15%-21.79M | -79.41%-17M | -16.36%-9.48M |
| Income tax | 1,100.00%120K | 100.00%10K | -44.44%5K | 200.00%9K | 3K | 0 | 0 | 90.43K | 0 | 79.27K |
| Net income | 30.40%-39.7M | -21.36%-57.04M | -39.93%-47M | 34.03%-33.59M | -67.78%-50.91M | -16.07%-30.35M | -19.48%-26.14M | -28.69%-21.88M | -77.92%-17M | -17.33%-9.56M |
| Net income continuous Operations | 30.40%-39.7M | -21.36%-57.04M | -39.93%-47M | 34.03%-33.59M | -67.78%-50.91M | -16.07%-30.35M | -19.48%-26.14M | -28.69%-21.88M | -77.92%-17M | -17.33%-9.56M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 30.40%-39.7M | -21.36%-57.04M | -39.93%-47M | 34.03%-33.59M | -67.79%-50.92M | -16.07%-30.35M | -19.48%-26.14M | -28.69%-21.88M | -77.92%-17M | -17.33%-9.56M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | |||||||
| Net income attributable to common stockholders | 30.40%-39.7M | -21.36%-57.04M | -39.93%-47M | 34.03%-33.59M | -67.79%-50.92M | -16.07%-30.35M | -19.48%-26.14M | -28.69%-21.88M | -77.92%-17M | -17.33%-9.56M |
| Basic earnings per share | 34.15%-1.08 | -21.48%-1.64 | 2.17%-1.35 | 41.28%-1.38 | -51.61%-2.35 | -3.33%-1.55 | -4.90%-1.5 | -19.17%-1.43 | -62.16%-1.2 | 2.63%-0.74 |
| Diluted earnings per share | 34.15%-1.08 | -21.48%-1.64 | 2.17%-1.35 | 41.28%-1.38 | -51.61%-2.35 | -3.33%-1.55 | -4.90%-1.5 | -19.17%-1.43 | -62.16%-1.2 | 2.63%-0.74 |
| Dividend per share | ||||||||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg